Sanofi (SNY) Non-Current Assets (2009 - 2026)

Sanofi has disclosed Non-Current Assets across 18 years of filings, most recently posting $113.4 billion for Q2 2026.

• In Q2 2026, Non-Current Assets rose 13.89% year-over-year to $113.4 billion; the TTM figure through Jun 2026 stood at $451.5 billion (up 14.09% YoY), while the FY2025 annual figure was $111.6 billion, up 14.28% from the prior year.
• Non-Current Assets came in at $113.4 billion for Q2 2026 at Sanofi, down from $114.6 billion in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $114.6 billion in Q1 2026 to a low of $92.4 billion in Q1 2025.
• Average Non-Current Assets over 5 years is $104.0 billion, with a median of $103.5 billion recorded in 2023.
• Year-over-year, Non-Current Assets retreated 7.9% in 2022 and grew 23.95% in 2026.
• Over 5 years, Non-Current Assets stood at $94.5 billion in 2022, then gained by 9.08% to $103.1 billion in 2023, then slipped by 6.47% to $96.4 billion in 2024, then advanced by 15.75% to $111.6 billion in 2025, then increased by 1.61% to $113.4 billion in 2026.
• Per Business Quant data, the three most recent Non-Current Assets figures were $113.4 billion in Q2 2026, $114.6 billion in Q1 2026, and $111.6 billion in Q4 2025.